News

Podcast

Podcast: This Week in Managed Care—Banning Gag Clauses and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the Senate overwhelmingly voting to ban pharmacist gag clauses; a study found the current vaccine pipeline for HIV, tuberculosis, and malaria may fall short; an expert noted a trend of healthcare cost data seeping into nonhealthcare companies’ earnings calls.

To listen, login to the website.

Listen above or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Read more about the stories in this podcast:

Senate Votes 98-2 to Ban Pharmacist Gag Clauses

Launch of Highly Efficacious HIV, Tuberculosis, and Malaria Vaccines Unlikely, Study Says

When Employee Healthcare Costs Move Stocks

A Multidisciplinary Approach to Managing Complexities in Cancer Care

Related Videos
Benjamin Chen, MD, PhD
Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center
Lynae Darbes, PhD
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Lynae Darbes, PhD
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Cathy Eng, MD, FACP, FASCO
Annie Antar, MD, PhD, Johns Hopkins Medicine
Related Content
AI technology | Image: Adobe Stock
April 17th 2025

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

Mary Caffrey
These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.
Managed Care Cast Thumbnail
April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
IVBM Atlanta | Image credit: AJMC
April 14th 2025

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

Kyle Munz
Coverage from the Atlanta Regional meeting of the Institute for Value-Based Medicine.
Managed Care Cast Logo
February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS
On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
AJMC
April 4th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

Galen Shearn-Nance, BS Rishi R. Sachdev, BS Long Vu, MS Weichuan Dong, PhD Alberto J. Montero, MD, MBA Siran M. Koroukian, PhD Johnie Rose, MD, PhD
This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Money | Image credit: Stillfx - stock.adobe.com
April 3rd 2025

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

Julia Bonavitacola
Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo